Brorphine, a synthetic opioid (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazole-2-one), has been placed in Schedule I under the DEA’s emergency scheduling authority (86 Fed. Reg. 11862, March 1, 2021). Notice of the DEA’s intent to take the scheduling action was published in the Federal Register on Dec. 3, 2020 (85 Fed. Reg. 78047), following recommenda... Read More